BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25248717)

  • 41. Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1.
    Pan D; Barber MA; Hornigold K; Baker MJ; Toth JM; Oxley D; Welch HC
    J Biol Chem; 2016 Mar; 291(12):6359-75. PubMed ID: 26792863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer.
    Jiao F; Bai SY; Ma Y; Yan ZH; Yue Z; Yu Y; Wang X; Wang J
    PLoS One; 2014; 9(3):e92190. PubMed ID: 24632672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
    Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
    BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
    Augoff K; McCue B; Plow EF; Sossey-Alaoui K
    Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
    Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
    OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
    Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
    BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.
    Sizemore ST; Sizemore GM; Booth CN; Thompson CL; Silverman P; Bebek G; Abdul-Karim FW; Avril S; Keri RA
    Breast Cancer Res Treat; 2014 Jul; 146(1):25-40. PubMed ID: 24847890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
    Szarc Vel Szic K; Declerck K; Crans RAJ; Diddens J; Scherf DB; Gerhäuser C; Vanden Berghe W
    Oncotarget; 2017 Jun; 8(25):40434-40453. PubMed ID: 28467815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits.
    Adame-García SR; Cervantes-Villagrana RD; Orduña-Castillo LB; Del Rio JC; Gutkind JS; Reyes-Cruz G; Taylor SS; Vázquez-Prado J
    J Biol Chem; 2019 Feb; 294(7):2232-2246. PubMed ID: 30530493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
    Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
    J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
    Nojima D; Li LC; Dharia A; Perinchery G; Ribeiro-Filho L; Yen TS; Dahiya R
    Cancer; 2001 Oct; 92(8):2076-83. PubMed ID: 11596023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
    Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
    Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
    Dillon LM; Bean JR; Yang W; Shee K; Symonds LK; Balko JM; McDonald WH; Liu S; Gonzalez-Angulo AM; Mills GB; Arteaga CL; Miller TW
    Oncogene; 2015 Jul; 34(30):3968-76. PubMed ID: 25284585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
    Mirza S; Sharma G; Pandya P; Ralhan R
    Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
    Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.